US 8987308
Compounds for the treatment of Clostridium difficile-associated disease
granted A61KA61K31/4164A61K31/424
Quick answer
US patent 8987308 (Compounds for the treatment of Clostridium difficile-associated disease) held by Summit Corporation Plc expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Summit Corporation Plc
- Grant date
- Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K31/4164, A61K31/424, A61K31/4365, A61K31/437